Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe

Benzinga03-25

• Baxter International stock is showing downward bias. Where is BAX stock headed? The shortage stems from a technical issue at a third-party manufacturing facility that disrupted production planning, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622092505?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/24/Stuttgart--Germany---03-31-2023-Person-H.jpeg?optimize=medium&dpr=2&auto=webp&width=260","is_english":true,"pubTime":"2026-03-25 01:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622092505","market":"us","top_or_hot":-1,"title":"Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe","media":"Benzinga","content":"<div>\n<p>• Baxter International stock is showing downward bias. Where is BAX stock headed?\nThe shortage stems from a technical issue at a third-party manufacturing facility that disrupted production planning, ...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/03/51439686/manufacturing-disruption-hits-baxter-cancer-drug-supply-in-europe\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nManufacturing Disruption Hits Baxter Cancer Drug Supply In Europe\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-25 01:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/26/03/51439686/manufacturing-disruption-hits-baxter-cancer-drug-supply-in-europe><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>• Baxter International stock is showing downward bias. Where is BAX stock headed?\nThe shortage stems from a technical issue at a third-party manufacturing facility that disrupted production planning, ...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/03/51439686/manufacturing-disruption-hits-baxter-cancer-drug-supply-in-europe\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/26/03/51439686/manufacturing-disruption-hits-baxter-cancer-drug-supply-in-europe","article_id":"2622092505","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/24/Stuttgart--Germany---03-31-2023-Person-H.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/03/51439686/manufacturing-disruption-hits-baxter-cancer-drug-supply-in-europe","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622092505","pubTimestamp":1774373040,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Baxter warns of an EU-wide ifosfamide shortage until next year after manufacturing disruption, with supply quotas and treatment prioritization in place.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","BAX":"百特国际","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","BK4082":"医疗保健设备","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","BK4504":"桥水持仓","LU2098885051.SGD":"JPMorgan Funds - Multi-Manager Alternatives A (acc) SGD","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC"},"translate_title":"生产中断影响了欧洲百特抗癌药物供应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAX":1.5},"content_text":"• Baxter International stock is showing downward bias. Where is BAX stock headed?\nThe shortage stems from a technical issue at a third-party manufacturing facility that disrupted production planning, inventory systems and product release cycles.\nThe site was also undergoing corrective actions after a regulatory inspection, compounding the disruption.\nBaxter, the primary supplier of ifosfamide in the EU, said manufacturing has resumed, but output remains limited.\nAs a result, the company is implementing a quota-based distribution system to manage existing inventory until supply normalizes.\nThe company emphasized that the shortage is not linked to any safety, efficacy or quality concerns with the currently available ifosfamide stock. However, supply interruptions are expected to vary by country, with all EU markets likely to experience constraints over time.\nIfosfamide is a cytotoxic chemotherapy agent widely used in both adults and children, either alone or in combination with other therapies, to treat a range of malignant conditions.\nTo mitigate the impact, Baxter is working with the European Medicines Agency and national regulators on coordinated response measures. Health care providers are being advised to secure an adequate supply before initiating new treatment courses.\nPhysicians may need to prioritize patients already undergoing therapy or those with limited alternative treatment options. In some cases, switching to alternative regimens in line with European guidelines or local protocols may be necessary.\nBaxter stock fell after the company guided fiscal 2026 adjusted earnings between $1.85-$2.05 per share, compared to the consensus of $2.25.\nAdjusted operating margin is expected to be between 13%-14%\nThe hospital product maker forecasts 2026 sales of $11.24 billion-$11.36 billion, compared to the consensus of $11.31 billion. Baxter expects 2026 sales growth to be flat to increase by 1%.\nBAX Stock Price Activity: Baxter shares were up slightly  at $16.63 at the time of publication on Tuesday according to Benzinga Pro data.\nImage via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622092505","isCrawlerRequest":true}